Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Vitae Pharmaceuticals, Inc (VTAE)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-15Dec-31-14Dec-31-13Dec-31-12
   10-K10-K10-K10-K
Revenues  0.68.722.522.3
            Revenue growth  -93.3%-61.5%0.7% 
Cost of goods sold  0.00.00.00.0
Gross profit  0.68.722.522.3
            Gross margin  100.0%100.0%100.0%100.0%
Selling, general and administrative   [+]9.37.95.44.9
Research and development  35.619.314.915.9
EBITDA   [+]-44.1-18.32.42.0
            EBITDA margin  -7602.6%-211.5%10.6%9.1%
Depreciation and amortization  0.20.20.20.5
EBIT   [+]-44.3-18.52.21.5
            EBIT margin  -7640.5%-214.0%9.7%6.7%
Interest expense, net   [+]-0.30.91.41.5
Other income (expense), net   [+]0.10.30.30.2
Pre-tax income  -44.0-19.11.20.2
Income taxes  0.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%
Net income  -44.0-19.11.20.2
            Net margin  -7587.5%-220.4%5.2%1.0%
   
Basic EPS   [+]($2.03)($3.61)$2.06$0.41
Diluted EPS   [+]($2.03)($3.61)$2.06$0.41
   
Shares outstanding (basic)   [+]21.65.30.60.5
Shares outstanding (diluted)   [+]21.65.30.60.5
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy